Fenoprofen calcium in rheumatoid arthritis. A controlled double-blind crossover evaluation.
D000893:Anti-Inflammatory Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000139:chemically induced; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D001219:Aspartate Aminotransferases / Q000097:blood; D001241:Aspirin / Q000009:adverse effects / Q000627:therapeutic use*; D001799:Blood Sedimentation; D001806:Blood Urea Nitrogen; D002118:Calcium; D002986:Clinical Trials as Topic; D003875:Drug Eruptions / Q000209:etiology; D005243:Feces / Q000032:analysis; D005260:Female; D006138:Guaiac / Q000032:analysis; D006261:Headache / Q000139:chemically induced; D006417:Hematuria / Q000139:chemically induced; D006801:Humans; D006863:Hydrogen-Ion Concentration; D008297:Male; D008875:Middle Aged; D009325:Nausea / Q000139:chemically induced; D010146:Pain; D010647:Phenyl Ethers / Q000009:adverse effects / Q000627:therapeutic use; D010919:Placebos; D011422:Propionates / Q000009:adverse effects / Q000627:therapeutic use*; D014012:Tinnitus / Q000139:chemically induced; D014527:Uric Acid / Q000097:blood; D014556:Urine; D014839:Vomiting / Q000139:chemically induced
D000893:Anti-Inflammatory Agents; D010647:Phenyl Ethers; D010919:Placebos; D011422:Propionates; D014527:Uric Acid; D006138:Guaiac; D001219:Aspartate Aminotransferases; D001241:Aspirin; D002118:Calcium